|
|
Volumn 9, Issue 11, 2001, Pages 2843-2848
|
|
A new acivicin prodrug designed for tumor-Targeted delivery
a
a
a
INSTITUT CURIE
(France)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,2 DIMETHYLPROPIONIC ACID 4 [CARBOXY (3 CHLORO 4,5 DIHYDROISOXAZOL 5 YL)METHYLCARBAMPYLOXYMETHYL] 2 [2 (3 CARBOXYMETHYLSULFANYL 2,5 DIOXOPYRROLIDIN 1 YL)ETHYLCARBAMOYL]PHENYL ESTER;
ACIVICIN;
ACIVIN DERIVATIVE;
ESTERASE;
GAMMA GLUTAMYLTRANSFERASE;
PRODRUG;
UNCLASSIFIED DRUG;
2,2 DIMETHYLPROPIONIC ACID 4 [CARBOXY (3 CHLORO 4,5 DIHYDROISOXAZOL 5 YL)METHYLCARBAMOYLOXYMETHYL] 2 [2 (3 CARBOXYMETHYLSULFANYL 2,5 DIOXOPYRROLIDIN 1 YL)ETHYLCARBAMOYL]PHENYL ESTER;
MONOCLONAL ANTIBODY;
PYRROLIDINE DERIVATIVE;
ARTICLE;
CELL PROLIFERATION;
CELL STRAIN HL 60;
CHEMICAL REACTION KINETICS;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG STABILITY;
DRUG SYNTHESIS;
ENZYME INHIBITION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN CELL;
HYDROLYSIS;
IN VITRO STUDY;
MASS SPECTROMETRY;
NUCLEAR MAGNETIC RESONANCE;
DRUG ACTIVITY;
DRUG HALF LIFE;
DRUG HYDROLYSIS;
DRUG RELEASE;
DRUG STRUCTURE;
ENZYME ACTIVITY;
LEUKEMIA CELL;
PH;
REACTION ANALYSIS;
|
|
EID: 0034807604
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(01)00145-6 Document Type: Article |
|
Times cited : (43)
|
|
References (18)
|
